More than 35 million people suffer from Alzheimer’s worldwide, a figure that could reach 100 million in less than 50 years according to the World Health Organization (WHO).
No significant therapeutic advances have been made since this condition was discovered, nor is a cure envisaged in the short term. However, we know that 20 years can elapse between onset of the lesions in the brain and appearance of the disease.
So prevention and early detection is one of the main research challenges. What are the major risk factors? What biological indicators do we know today that may indicate appearance of the disease prior to the first clinical symptoms? How can cognitive deterioration be minimised and quality of life improved for patients and their carers? How are new therapies being designed?
Mercè Boada, doctor and neurologist, founder and medical director of Fundació ACE. The Government of Catalonia awarded her the St. George's Cross distinction in 2016.
Arcadi Navarro, Professor of genetics and ICREA research professor in the Pompeu Fabra University. Director of the Barcelona Brain Research Center (BBRC) and of the Pasqual Maragall Foundation.
Michele Catanzaro, journalist specialised in research and health at El Periódico and doctor in physics.